Combining the farnesyltransferase inhibitor lonafarnib with paclitaxel results in enhanced growth inhibitory effects on human ovarian cancer models in vitro and in vivo
Stacey A. Taylor, Cindy H. Marrinan, Gongjie Liu, Lissette Nale, W. Robert Bishop, Paul Kirschmeier, Ming Liu, Brian J. LongVolume:
109
Year:
2008
Language:
english
DOI:
10.1016/j.ygyno.2007.12.013
File:
PDF, 1.07 MB
english, 2008